ENVALITH
SEMITEC株式会社 logo

SEMITEC Corporation

6626Standard MarketElectric Appliances

SEMITEC株式会社 logo
SEMITEC Corporation6626

Business

SEMITEC Corporation, founded in 1958, is a dedicated sensor manufacturer that develops, manufactures, and sells Temperature Sensors (Thermistors) as its core product, alongside bulk sensors, thin-film sensors, infrared sensors, and other products. Its domestic Chiba Plant serves as the core hub for R&D and production, and the company operates a total of 13 consolidated subsidiaries across the United States, Hong Kong, Taiwan, South Korea, the Philippines, Thailand, Vietnam, India, Germany, and other locations. Its main customers span automotive (for HEV battery and motor applications), medical (blood glucose meters), industrial equipment, home appliance and housing equipment, and OA equipment manufacturers, making it a truly global company with overseas sales accounting for more than 80% of total revenue. Consolidated net sales for FY2026 (ending March 2026) were ¥25,458 million.

Business Model

The company combines "local-for-local production" near consumption markets with "cost-optimized production" leveraging low-cost labor, manufacturing products at overseas bases in the Philippines, Thailand, Vietnam, China, and other locations, and selling directly to customers through regional sales subsidiaries. Revenue is managed by region across four segments—Japan, Greater China, Other Asia, and North America—and earnings stability is pursued through diversification of applications such as automotive, medical, and industrial equipment. Key management indicators are operating profit amount and ROIC (target of 9% or higher; FY2026 (ending March 2026) actual result of 11.0%).

Company Strengths

The company began manufacturing thin-film sensors utilizing semiconductor thin-film technology in 1992, accumulating over 30 years of technological expertise. R&D expenses overseen by the World Technology Center at the Chiba Plant reached ¥1,173 million in FY2026 (ending March 2026), continuously generating product lineups that are difficult for competitors to easily replicate, such as compact sensors for medical applications and high-precision pairing technology.

At the end of FY2026 (ending March 2026), equity capital stood at ¥23,854 million, with an equity ratio of 77.4%. Against cash and cash equivalents of ¥9,619 million, interest-bearing debt remained limited to ¥2,270 million, maintaining a virtually debt-free management structure in which cash and deposits substantially exceed interest-bearing debt. This financial capacity enables capital expenditures (¥2,773 million in FY2026) and share buybacks (¥2,399 million in the same period).

Sales are diversified across four segments—Japan, Greater China, Other Asia, and North America—with applications also diversified across automotive, medical, industrial equipment, home appliances, and OA equipment. Through a direct sales structure via 13 overseas bases including in the Philippines, Thailand, Vietnam, South Korea, and India, the company possesses sales capability that captures region-specific needs while curbing excessive dependence on any particular region or application.

ENVALITH's Perspective

Net sales came in at ¥25,458 million (up 0.4% year on year), a marginal increase, while operating profit fell to ¥3,535 million (down 9.7%), ordinary profit to ¥3,611 million (down 11.0%), and net income attributable to owners of parent to ¥2,690 million (down 13.5%), representing a decline in profit at every stage. As an external factor, surging raw material prices and rising labor costs squeezed gross profit (gross profit of ¥9,576 million versus ¥9,792 million in the prior period), while R&D expenses expanded from ¥996 million to ¥1,174 million. The recording of a loss on retirement of fixed assets of ¥97 million (versus ¥13 million in the prior period) also weighed down ordinary profit.

The consolidated earnings forecast for FY2027 (ending March 2027) calls for net sales of ¥24,890 million (down 2.2% year on year), operating profit of ¥2,950 million (down 16.5%), and net income of ¥2,050 million (down 23.7%), indicating a substantial decline in profit. Increased depreciation expenses associated with the launch of new Thin-Film Thermistor production equipment is explicitly cited as a temporary factor squeezing profitability, while, as an external factor, the risk of higher raw material and logistics costs stemming from the situation in the Middle East remains an uncertainty not yet incorporated into the earnings forecast.

The segment loss in the Japan segment widened to ¥571 million (versus a loss of ¥444 million in the prior period), primarily due to increased R&D expenses and other costs. Meanwhile, during the period the company acquired ¥2,400 million of treasury stock (treasury shares outstanding at period-end of 1,776 thousand shares, versus 730 thousand shares in the prior period), and also raised the dividend to ¥47 per share (versus ¥40 in the prior period), with ¥56 planned for FY2027 (ending March 2027). Amid a sharp decline in operating cash flow to ¥2,907 million (versus ¥5,191 million in the prior period), this aggressive shareholder return policy has entailed a drawdown of the company's cash position (¥9,619 million at period-end), making the balance with future investment capacity a point of attention going forward.

Growth Strategy

Rebuilding the earnings base through focused expansion in the automotive and medical markets and the launch of new Thin-Film Thermistors production equipment

In FY2026 (ending March 2026), the company invested ¥2,614 million in fixed asset acquisitions for new Thin-Film Thermistors production equipment. Operations are scheduled to commence from FY2027 (ending March 2027). Depreciation expenses will temporarily increase, but the company aims to improve profitability over the medium to long term by strengthening its production capacity for high-value-added products.

Automotive applications grew to ¥10,004 million (up 6.1% year on year) in FY2026 (ending March 2026), the largest among all applications. The company continues to focus on expanding sales of sensors for Korean HEV batteries and motors, and sensors for blood glucose meters for the North American medical market. North America segment profit increased 11.2% year on year to ¥1,050 million, maintaining its growth trajectory.

Production consolidation was carried out through the transfer of the equity interest in Jiangsu Xingshun Electronics Co., Ltd. (completed in FY2026, ending March 2026). Despite a decline in revenue, the Greater China segment achieved a 5.8% increase in profit, reflecting the emerging effects of cost reductions. The company will continue to promote efficiency improvements at its China subsidiaries to maintain and enhance profitability.

The dividend for FY2026 (ending March 2026) was increased to ¥47 per share (from ¥40 in the previous fiscal year), representing a payout ratio of 17.0%. For FY2027 (ending March 2027), the dividend is planned at ¥56 per share (payout ratio of 26.2%). The company also conducted share buybacks totaling ¥2,400 million, bringing total shareholder returns to ¥2,825 million. The company has explicitly stated its policy of continuing to strengthen returns even in a phase of declining profits.

Last updated: July 19, 2026